Trending stocks

People Corp Debt jumped on 163% in 2015 and Revenue jumped on 15.8%

14.12.2015 • About People Corp ($PEO) • By InTwits

People Corp reported FY2015 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • People Corp has low CAPEX intensity: 5 year average CAPEX/Revenue was 1.4%. At the same time it's a lot of higher than industry average of 84.8%.
  • CAPEX is quite volatile: 0.73 in FY2015, 1.1 in FY2014, 0.40 in FY2013, 0.17 in FY2012, 0.31 in FY2011
  • The company has potentially unprofitable business model: ROIC is at 6.6%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

People Corp ($PEO) key annual financial indicators

mln. CAD201120122013201420152015/2014
P&L
Revenue24.41427.15732.89242.57649.29315.8%
SG&A7.1198.008
EBITDA2.2532.6074.2077.3447.8567.0%
Net Income0.4710.7260.2601.5411.394-9.5%
Balance Sheet
Cash1.2883.2002.4492.7506.515136.9%
Short Term Debt0.7610.4653.8043.0812.472-19.8%
Long Term Debt2.2031.77115.4456.58022.937248.6%
Cash flow
Capex0.3060.1650.3951.1180.734-34.4%
Ratios
Revenue growth18.0%11.2%21.1%29.4%15.8%
EBITDA growth20.6%15.7%61.4%74.5%7.0%
EBITDA Margin9.2%9.6%12.8%17.2%15.9%-1.3%
Net Income Margin1.9%2.7%0.8%3.6%2.8%-0.8%
SG&A, % of revenue26.2%24.3%0.0%
CAPEX, % of revenue1.3%0.6%1.2%2.6%1.5%-1.1%
ROIC6.1%8.4%9.3%11.4%6.6%-4.9%
ROE3.7%5.4%1.9%7.7%4.0%-3.7%
Net Debt/EBITDA0.7x-0.4x4.0x0.9x2.4x1.5x

Revenue and profitability


The company's Revenue jumped on 15.8% in FY2015. Revenue growth was financed by EBITDA margin decline. EBITDA Margin decreased slightly on 1.3 pp from 17.2% to 15.9% in FY2015.

Net Income marign decreased slightly on 0.79 pp from 3.6% to 2.8% in FY2015.

Capital expenditures (CAPEX) and working capital investments


In FY2015 People Corp had CAPEX/Revenue of 1.5%. CAPEX/Revenue increased slightly on 0.88 pp from 0.61% in FY2012 to 1.5% in FY2015. For the last three years the average CAPEX/Revenue was 1.8%.

Return on investment


The company operates at low ROIC (6.56%) and ROE (3.98%). ROIC decreased on 4.9 pp from 11.4% to 6.6% in FY2015. ROE decreased on 3.7 pp from 7.7% to 4.0% in FY2015.

Leverage (Debt)


Company's Net Debt / EBITDA is 2.4x and Debt / EBITDA is 3.2x. Net Debt / EBITDA jumped on 1.5x from 0.9x to 2.4x in FY2015. Debt jumped on 163% in FY2015 while cash jumped on 137% in FY2015.

Appendix 1: Peers in Consumer, Non-cyclical


Below you can find People Corp benchmarking vs. other companies in Consumer, Non-cyclical industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
GDI Integrated Facility Services Inc ($GDI)43.8%-38.8%-72.9%218,969.1%
Cardiome Pharma Corp ($COM)-97.7%-47.6%471.7%566.0%
Family Memorials Inc ($FAM)-13.6%54.7%22.9%245.3%
Nobilis Health Corp ($NHC)16.6%45.3%49.0%169.9%
Concordia Healthcare Corp ($CXR)159.5%
 
Median (85 companies)12.3%7.7%6.0%12.2%6.0%
People Corp ($PEO)11.2%21.1%29.4%15.8%


Top companies by Gross margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Nobilis Health Corp ($NHC)99.8%
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%
Heritage Global Inc ($HGP)99.5%95.7%
Ritchie Bros Auctioneers Inc ($RBA)87.9%88.7%88.4%88.0%
Concordia Healthcare Corp ($CXR)79.4%86.0%
 
Median (74 companies)34.5%36.1%35.9%35.1%28.1%


Top companies by EBITDA margin, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Cipher Pharmaceuticals Inc ($CPH)-50.0%40.6%71.4%63.7%
Merus Labs International Inc ($MSL)32.9%64.7%46.2%61.5%
Valeant Pharmaceuticals International Inc ($VRX)37.0%30.6%27.8%45.6%
EnerCare Inc ($ECI)59.0%52.8%51.0%45.5%
Information Services Corp ($ISV)34.1%39.6%39.6%37.6%
 
Median (84 companies)7.9%7.9%8.3%10.5%8.6%
People Corp ($PEO)9.2%9.6%12.8%17.2%15.9%


Top companies by CAPEX/Revenue, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Neptune Technologies & Bioressources Inc ($NTB)6.0%4.7%73.6%84.6%119.0%
CanaDream Corp ($CDN)68.6%43.3%38.1%70.4%63.4%
Ceapro Inc ($CZO)2.2%3.9%35.3%52.0%
Feronia Inc/Canada ($FRN)129.0%191.4%117.4%42.4%
Microbix Biosystems Inc ($MBX)1.0%1.2%3.0%40.3%
 
Median (85 companies)2.4%2.6%2.5%2.4%2.7%
People Corp ($PEO)1.3%0.6%1.2%2.6%1.5%


Top companies by ROIC, %

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Biosyent Inc ($RX)45.5%71.7%62.4%62.9%
Information Services Corp ($ISV)56.0%71.8%72.8%58.9%
Covalon Technologies Ltd ($COV)-49.6%-75.8%-30.1%50.6%
Cipher Pharmaceuticals Inc ($CPH)-22.9%21.8%81.4%44.6%
Ceapro Inc ($CZO)69.9%-33.5%15.5%43.5%
 
Median (85 companies)8.0%6.7%6.7%6.9%7.5%
People Corp ($PEO)6.1%8.4%9.3%11.4%6.6%


Top companies by Net Debt / EBITDA

Top 5 FY2011 FY2012 FY2013 FY2014 FY2015
Noble Iron Inc ($NIR)25.5x12.9x227.3x
Family Memorials Inc ($FAM)15.2x
Amica Mature Lifestyles Inc ($ACC)11.7x9.4x14.7x13.8x12.3x
Cott Corp ($BCB)2.6x2.0x2.2x13.4x
CRH Medical Corp ($CRH)-2.3x-3.1x-3.5x12.0x
 
Median (69 companies)1.9x2.8x2.1x2.7x1.4x
People Corp ($PEO)0.7x-0.4x4.0x0.9x2.4x